Stability testing guidance gets stickier
Executive Summary
FDA's 1revised guidance on stability testing of drug products raises the relative humidity recommendation for "general case" intermediate storage from 60% to 65%. The change "is intended to harmonize the intermediate storage condition for [climatic] zones I and II with the long-term condition for zones III and IV," FDA says. The Pharmaceutical Research & Manufacturers of America had been pressing for the modification to the 2001 guidance (2"The Pink Sheet" Jan. 6, 2003, p. 20)...
You may also be interested in...
ICH Harmonized Global Stability Testing Recommendations Sought By PhRMA
The Pharmaceutical Research & Manufacturers of America and the European Federation of Pharmaceutical Industries Associations have convened a working group to establish harmonized global stability testing recommendations for drug products across climatic zones
Investors Go Berserk For Viking, Putting It Top Of Q1 Winners
The top 10 biggest share price winners and losers in Q1 from Evaluate show the investor frenzy for obesity drugs continues, while companies with governance doubts see shareholders retreat.
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.